Skip to main content
TipRanks
Go Ultimate75% OFF

InnoPharmax, Inc. (4172) Balance Sheet

InnoPharmax, Inc. Balance Sheet

InnoPharmax, Inc.'s total assets for Q2 2026 were NT$581.33M, an increase of 23.96% from the previous quarter. TW:4172 total liabilities were NT$51.61M for the fiscal quarter, a 3.63% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 468.98MNT$ 633.06MNT$ 524.20MNT$ 489.31MNT$ 556.16M
NT$ 49.80MNT$ 30.21MNT$ 48.65MNT$ 58.31MNT$ 24.61M
NT$ 419.18MNT$ 602.85MNT$ 475.55MNT$ 431.00MNT$ 531.54M

Currency in TWD

InnoPharmax, Inc. Liabilities to Assets

0250M500M750M0 %12 %24 %36 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets